StockData
AVAIOTCServices-Computer Processing & Data PreparationFiscal year ends March 31

AVAI BIO, INC.

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.11−0.00 (-1.75%)

Close on Oct 19, 2026

Market cap
$17.24M
P/E (TTM)
–
Dividend yield
–

AVAI BIO, INC. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2026
79.9%

Financial strength

Current ratio
0.04
Debt to equity
–
Debt to assets
–
Cash to current liabilities
2.1%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–